102 related articles for article (PubMed ID: 300542)
1. Oxazepam disposition in uremic patients.
Odar-Cederlöf I; Vessman J; Alván G; Sjöqvist F
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):52-62. PubMed ID: 300542
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oxazepam in healthy volunteers.
Alván G; Siwers B; Vessman J
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):40-51. PubMed ID: 300541
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic profile of oxazepam.
Alván G; Odar-Cederlöf I
Acta Psychiatr Scand Suppl; 1978; (274):47-55. PubMed ID: 282777
[TBL] [Abstract][Full Text] [Related]
4. First pass conjugation and enterohepatic recycling of oxazepam in dogs; intravenous tolerance of oxazepam in propylene glycol.
Alván G; Jönsson M; Sundwall A; Vessman J
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):16-27. PubMed ID: 300540
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of oral dosage forms of oxazepam--correlation with in vitro dissolution rate.
Pilbrant A; Glenne PO; Sundwall A; Vessman J; Wretlind M
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):7-15. PubMed ID: 322447
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease.
Busch U; Molzahn M; Bozler G; Koss FW
Arzneimittelforschung; 1981; 31(9):1507-11. PubMed ID: 7197965
[TBL] [Abstract][Full Text] [Related]
8. Disposition of three benzodiazepines after single oral administration in man.
Wretlind M; Pilbrant A; Sundwall A; Vessman J
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):28-39. PubMed ID: 15399
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oxazepam given during labour.
Tomson G; Lunell NO; Sundwall A; Rane A
Acta Psychiatr Scand Suppl; 1978; (274):75-81. PubMed ID: 282778
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate.
Dreyfuss D; Shader RI; Harmatz JS; Greenblatt DJ
J Clin Psychiatry; 1986 Oct; 47(10):511-4. PubMed ID: 3759915
[TBL] [Abstract][Full Text] [Related]
11. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
Albanus L; Jönsson M; Sparf B
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
[TBL] [Abstract][Full Text] [Related]
12. Oxazepam kinetics: effects of age and sex.
Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
J Pharmacol Exp Ther; 1980 Oct; 215(1):86-91. PubMed ID: 7452494
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
14. Absorption and disposition of ibuprofen in hemodialyzed uremic patients.
Senekjian HO; Lee CS; Kuo TH; Au DS; Krothapalli R
Eur J Rheumatol Inflamm; 1983; 6(2):155-62. PubMed ID: 6673979
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
16. Absorption of diazepam after its rectal administration in dogs.
Papich MG; Alcorn J
Am J Vet Res; 1995 Dec; 56(12):1629-36. PubMed ID: 8599525
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics of oxazepam.
Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of benzodiazepine disposition by disulfiram and ethanol.
Sellers EM; Giles HG; Greenblatt DJ; Naranjo CA
Arzneimittelforschung; 1980; 30(5a):882-6. PubMed ID: 6106489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
